Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 104722

AbstractCase ReportDiscussionReferences
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"

Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018

Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."

Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018

Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."

Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018

Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."

Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
On Sep 2018

Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."

Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata

Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
On Aug 2018

Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".

Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
On Aug 2018

Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".

Dr. Mamta Gupta
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018

Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.

Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."

Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
On May 11,2011

Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."

Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
On April 2011

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.

Dr. Anuradha
On Jan 2020

Important Notice

Case report
Year : 2010 | Month : April | Volume : 4 | Issue : 2 | Page : 2300 - 2307 Full Version

A Large Mixed Radiolucent-Radiopaque Lesion In The Mandible- A Nobel Diagnostic Approach

Published: April 1, 2010 | DOI:

*(MDS), Private Practice, Interplast Fellowship In Plastic Surgery, Oral&Maxillofacial Surgery And OralImplantology,**(MDS)Dr.D.Y.Patil Dental College,Dept:Periodonticsand Oral Implantology,DrD.YPatil University,***(MDS)Muzaffarnagar Medical College, Professor(Prosthodontics),CSS University,**** (MDS)BJS,Dental College,Dept: Community Dentistry(Senior Lecturer),Ludhiana,(India)*****(BDS)Private Practice,******(MDS), Prosthodontics Al –Azhar Dental College,Thodupuezha,Kerala,(India).

Correspondence Address :
Dr. Sanjay Rastogi,House no.Z-22, Ashiyana Phase II; Moradabad (UP)-44001 (India)


Ameloblastoma is a true neoplasm of the enamel organ type tissue which does not undergo differentiation to the point of enamel formation. The term unicystic is derived from the macroscopic and microscopic appearance of the lesion. It is a well-defined, often large monocytic cavity with a lining focally, but rarely entirely composed of odontogenic (ameloblastomatous) epithelium. Predominant radiographical patterns for Unicystic Ameloblastoma are unilocular, scalloped, macromultilocular, pericoronal, interradicular, or periapical expansile radiolucencies. Some investigators believe that Unicystic Ameloblastoma arises from preexisting odontogenic cysts, in particular, from the dentigerous cyst, while others arise de novo. Immunohistochemical markers like lectins (Ulex europaeus agglutinin I and Bandeirea simplicifolia agglutinin I) and proliferating cells (proliferating cell nuclear antigen and Ki-67) may assist in their differential diagnosis. Hence, in our case report, we have tried to discuss in detail about the clinical, radiographical and histopathological features with differential diagnosis. The immunohistochemical importance has also been discussed.


Unicystic ameloblastoma, radiolucent, radiopaque, PCNA, ki-67

Tumors and tumor-like growths arising from odontogenic tissues constitute a heterogenous group of particularly interesting lesions, as they display the various inductive interactions that normally occur among the embryological components of the developing tooth germ. In humans, tumors of odontogenic tissues are comparatively rare, comprising of about 1% of all jaw tumors. Ameloblastomas constitute almost half (48.9%) of the odontogenic tumors with female-to-male and maxilla-to-mandible ratios of 1:1.7 and 1:8, respectively. The mean (SD) age of the patients in this group was 15.1 (± 3.0) years (range, 4–19 years), with most patients (49%) in the age group of 3 years. Multicystic/solid and unicystic variants were diagnosed in 40 (89%) and 5 (11%) cases respectively. This case report described the systematic approach towards the diagnosis and treatment of this unique entity.

Case Report

A 46yr old male patient reported to our Outpatient department with a gradually increasing painless swelling on the right lower third of the face for the past one year. History revealed that the swelling was about 2x2cm when first noticed, which gradually increased to the present size of 6x7cm. There was no history of anesthesia or paraesthesia. On examination, the swelling was found to be confined to right lower jaw (Table/Fig 1). Buccal and lingual cortical plate expansion was appreciated irt right canine to right third molar in the lower jaw , with palpable stony hard mass in the buccal and lingual vestibule in the same region and was non-tender. Mucosa over the swelling was normal, with no secondary changes (Table/Fig 2).A provisional diagnosis of benign odontogenic neoplasm was made.

Vitality test of 31 to 34 and 41 to 48 showed normal response. On fine needle aspiration, a white cheesy material was aspirated, whose protein content was found to be 3.2gm/dl. The orthopantamograph revealed an expansile, mixed, radiolucent-radiopaque lesion in the body of the mandible, extending from 41 to 48 and which surprisingly had crossed the midline and extended upto 34 (Table/Fig 3) . The borders of the lesion were well-defined on all aspects, except distal to 48. The inferior alveolar canal was displaced inferiorly, with the resorption of apical third of roots irt lower central incisor to lower canine on the left side and from lower right side central incisor to lower right third molar on the intra-oral periapical radiograph. Fine radiopaque flecks along with loss of the trabeculae, was evident within an intense well-defined radiolucency irt lower right second premolar to lower right second molar (Table/Fig 4).Computed tomography on axial section at the level of the mandible revealed an expansile lesion within the mandible, with hypodense areas on the anterior half of the lesion (Table/Fig 5) . A 3-D reconstructed image of CT revealed multiple septae within the lesion (Table/Fig 6) .

Differential Diagnosis
The first in the list of differential diagnosis was Ameloblastoma, as it is the most common benign odontogenic tumor occurring in middle aged individuals and in the mandibular posterior region. It also presents with buccal and lingual cortical plate expansion and presents with multilocular radiolucency, but it rarely shows flecks of calcification. The next entity that was considered was Calcifying epithelial odontogenic tumor (CEOT), as this too has a predilection for the age range of 30-50 yrs and for the posterior areas of the mandible. CEOT presents as slow growing lesions and also reveals focal areas of calcification within the lesion, on radiographs. Odontogenic Keratocyst (OKC), commonly occurs in the mandibular posterior region and it has a tendency to grow in the anterior-posterior direction within the medullary cavity of the bone without causing obvious bone expansion. The margins tend to be densely sclerotic, with a scalloped outline and rarely cause root resorption of the adjacent teeth. The other lesions that can be considered for differential diagnosis are Central giant cell granuloma and Odontogenic myxoma (1),(2),(3),(4),(5).Central giant cell granuloma (CGCG) presents with multilocular radiolucency and often shows the resorption of the root surfaces of the adjacent teeth, as seen in our case (1),(2),(3). The main characteristics which are useful for differentiating Ameloblastoma and CGCG are: Ameloblastomas tend to occur in an older age group and more often in the posterior mandible, and have coarse, curved, well-defined trabeculae. CGCG typically occurs anterior to the mandibular first molar and often crosses the midline (3). CGCGs may have sclerotic borders. Internally, the lesion may be radiolucent or granular, or may contain thin wispy septa. CGCGs show uneven expansion or are undulating in nature, which may give the appearance of a double boundary (2).Odontogenic Myxoma in the early stage has an osteoporotic appearance, consisting of multilocular radiolucency with well-developed locules. In the second stage of break-out or in the destructive phase, it is characterized by loss of locules with significant expansion. These lesions may cross the midline and may cause root resorption and tooth displacement (1),(2),(3),(4),(5) (Table/Fig 7) .(Table 1-2)

Surgical treatment of the right hemimandibulectomy, sparing the right condyle, was done (Table/Fig 8) (Figure7). The lesion was gently curetted out of marrow space by preserving the lingual periosteum. The lingual cortical plate was spared and one half of the genial musculature was preserved to prevent the back fall of the tongue. The surgically excised area was rehabilitated with an iliac crest graft. A bi-cortical iliac crest graft was harvested and minor adjustment in the graft was done to allow it to passively fit into the defect. An 8mm stainless steel screw was used to secure the graft on a pre-bent and adopted titanium plate (2.5mm). The patient is being followed-up for the past 1 ½yrs and the excised area shows eventful healing (Table/Fig 9). (Figure8)

Microscopic examination of the specimen revealed the presence of a well encapsulated lesion, with parakeratinized lining epithelium, showing keratin flakes and basal cell nuclei. Anatomizing cords and strands of odontogenic epithelium, bound by columnar to cuboidal shaped ameloblast-like cells, surrounding more loosely arranged stellate reticulm- like cells, were noted. All these features were suggestive of Unicystic ameloblastoma with plexiform pattern (Table/Fig 10) (Figure 9) (6).

The Formalin tissue fixed block was treated with Antigen retrieval of Heat Induced Epitome Retreival. Primary antibodies of the Ki 67 Antigen (clone: BGX-Ki67) and PCNA (clone: PC-10) was used. The polymer-HRP detection system and DAB chromogen was used. Positivity was considered when nuclei of the positive cells took up brown colour. Both PCNA and Ki 67 positivity was seen in few scattered tumour epithelial cells which were distributed focally, especially more in the periphery (Table/Fig 10) (Figure 10,11). Hence, even immunohistochemically, the lesion was distinguished from other odontogenic cysts.

Historical Review
Cusack JW (1827) first published a case, which was obviously an ameloblastoma. But, the detailed histopathological description was first made by Wedl (1853). He called the tumour,“Cystosarcoma or Cystosarcoma Adenoids”, but suggested that it could have arisen from a tooth bud or from the dental lamina. Broca (1868) gave the first detailed description of solid/multicystic ameloblastoma, whereas the first histological drawing of ameloblastoma was made by Wagstaffe (1871). The detailed description of ameloblastoma was made by Falksson (1879). Malassez (1885) suggested the name “Epithelioma Adamantin”. Derjinsky (1890) suggested the term “Adamantinoma” .

Ivey and Churchill (1930) used the name “Ameloblastoma”. The first case of Peripheral Ameloblastoma, was made by Stanley and Krough (1959) (3),(7). The concept of Unicystic Ameloblastoma (UA) was first introduced by Robinson and Martinez (1977), where they associated UA with dentigerous cysts, cytogenic ameloblastoma, extensive dentigerous cysts with intracystic ameloblastic papilloma, mural ameloblastoma, dentigerous cysts with ameloblastomatous proliferation and ameloblastoma developing in a radicular (or “globulomaxillary”) cyst (8),(9).Gardner DG (1981) described a subtype of UA, plexiform UA, where the inner surface of the cyst may show one or several polypoid or papillomatous, pedunculated, exophytic masses, which in rare cases, fill the entire cyst lumen (10). This subtype has also been called as intracystic, luminal or intraluminal ameloblastoma (9).


Ameloblastoma is a true neoplasm of the enamel organ type tissue which does not undergo differentiation to the point of enamel formation. Robinson (1937) described it as unicentric, nonfunctional, intermittent in growth, anatomically benign and clinically persistent (3),(4). WHO (1992) has described Ameloblastoma as a benign, locally aggressive, polymorphic neoplasm, which is presumably derived from the intraosseous remnants of the odontogenic epithelium.(5),(6) Various synonyms which are used for ameloblastoma are Adamantinoma, Adamantoblastoma, Epithelioma Adamantin, Multilocular Cyst, Adontomes embryolastiques and Epithelial odontoma (3),(7).
A recently published biological profile based on 3,677 ameloblastoma cases, has clearly demonstrated that it is no longer appropriate in any scientific study to use the diagnosis of ameloblastoma without specifying the type. Hence, based on clinical and radiographical characteristics, histopathology, and behavioural and prognostic features, subtypes or variants of ameloblastomas can be presently distinguished as follows (7):
1. The classic solid/ multicystic ameloblastoma (SMA)
2. The unicystic ameloblastoma (UA)
3. The peripheral ameloblastoma (PA)
4. The desmoplastic ameloblastoma (DA), including the so-called hybrid lesions

The term ‘unicystic’ is derived from the macro- and microscopic appearance of the lesion. It is a well-defined, often large monocytic cavity with a lining focally, but which is rarely entirely composed of odontogenic (ameloblastomatous) epithelium (10),(11). Much confusion stems from the fact that a unicystic ameloblastoma may appear not only as a unilocular, but also as a multilocular bone defect (12). UA can be divided into 2 categories (9):
1. Histologically verified UAs which are associated with an unerupted tooth (dentigerous variant)
2. UAs lacking an association with an unerupted tooth ( nondentigerous variant)

No data are available concerning the prevalence and incidence of UAs. The relative prevalence and incidence of UAs have been reported as between 5-22% of all types of ameloblastomas (13). UAs are more commonly seen in younger patients, with 50% of cases being diagnosed during the second decade of life. The average age in one large series was found to be 23 years (14),(15),(16). The gender distribution shows a slight male predilection with a male:female ratio of 1.6:1. However, when the tumor is not associated with an un-erupted tooth, the gender ratio is reversed to a male to female ratio of 1:1.8 (16).

Clinically, UA presents as a localized swelling, with occasional pain and signs of lip numbness. In cases of secondary infection, discharge or drainage can be noted (9),(15),(16). The location of UA within the jawbone shows a marked predominance for the mandible, irrespective of the variant. The ratio of the maxilla: mandible is 1:7 for the dentigerous variant, versus 1:4.7 for the nondentigerous type (9),(15). Radiographically, UAs have been divided into 2 main patterns: unilocular and multilocular. UAs have clear preponderance for the uniclocular pattern. This preponderance is predominantly marked for the dentigerous variant, where the unilocular to multilocular ratio is 4.3:1 and for the nondentigerous type, this ratio is 1.1:1(9),(12). Eversole LR et al identified (6) predominant radiographical patterns for UA: unilocular, scalloped, macromultilocular, pericoronal, interradicular, or periapical expansile radiolucencies (12).

Some investigators believe that UA arises from preexisting odontogenic cysts, in particular a dentigerous cyst, while others maintain that it arises de novo. Robinson and Martinez (1997) argued that as the epithelium of odontogenic cysts and ameloblastomas have a common ancestry, a transition from a non-neoplastic to a neoplastic one could be possible, even though it occurs infrequently (8).Leider AS et al (1985) proposed three pathogenic mechanisms for the evolution of UA: (17).

The reduced enamel epithelium which is associated with a developing tooth undergoes ameloblastic transformation with subsequent cystic development
1. Ameloblastomas arise in dentigerous cysts or in other in which the neoplastic ameloblastic epithelium is preceded temporarily by a non-neoplastic stratified squamous epithelial lining.
2. A solid ameloblastoma undergoes cystic degeneration of the ameloblastic islands, with subsequent fusion of multiple microcysts and develops into unicystic lesions.
Li TJ et al (1995) made a comparison of proliferating cell nuclear antigen (PCNA) expression in the cystic tumour lining of UAs and found that all areas of the UA lining contained significantly more PCNA-positive cells than in the dentigerous cyst linings, even in areas where the epithelial morphology was similar to that of the dentigerous cyst lining. This finding was interpreted as favorable to the concept that UAs are de novo cystic neoplasms (18). The 1992 edition of the WHO classification distinguishes between the three histological subtypes of UA which correspond to the subgroups 1, 1.2 and 1.3. Subgroup 1 has an epithelial lining, of which some parts may show transformation to cuboidal or columnar basal cells with hyperchromatic nuclei, nuclear palisading with polarization, cytoplasmic vacuolization with intercellular spacing and subepithelial hyalinization. Subgroup 1.2 shows a combination of simple and intraluminal histological features. UA subgroup 1.2.3 shows the presence of intramural ameloblastoma tissue, as well as the subgroup 1.2. The last subgroup 1.3 exhibits a cyst with a luminal lining in combination with intramural nodules of solid / multicystic ameloblastoma (6),(9). Hence, the case reported in this article corresponds to subgroup 1.3.

Several attempts have been made in the past to distinguish the lining of the UAs from that of odontogenic cysts. The immunohistochemical expression of blood cell carbohydrates and the epidermal growth factor receptor have shown no consistent difference between the odontogenic cysts and UA. However, immunohistochemical markers like lectins (Ulex europaeus agglutinin I and Bandeirea simplicifolia agglutinin I) and proliferating cells (proliferating cell nuclear antigen and Ki-67) may assist in their differential diagnosis.18,19,20 Similarly, in our case, the immunohistochemical markers showed positive expression: PCNA and Ki-67 were noted more in the region of tumour islands and less in the cystic lining region. The cystic lining, particularly of OKC, typically reveals positivity for these proliferating markers. Hence, the lesion of our case was differentiated from the cysts of odontogenic origin.

Treatment planning depends on the histological type of UA. UA which is diagnosed as subgroups 1 and 1.2 may be treated conservatively (careful enucleation), whereas subgroups 1.2.3 mad 1.3 should be treated aggressively (16),(21). The histological typing of the current case was 1.3 and hence, the lesion was treated aggressively with surgical resection. The recurrence rate for UAs after conservative surgical treatment (curettage or enucleation) are generally reported to be 10-20%, (16) and on average, less than 25% (22). This is considerably less than 50-90% recurrence rates which are noted after the curettage of conventional solid or multicystic ameloblastomas (16).

Ameloblastoma is the most common odontogenic neoplasm. It presents with a numerous variety of clinical, radiographical and histopathological features. UA, a type of Ameloblatoma, too presents with a variety of clinical, radiological and histopathological features. Hence, it presents as a challenge both for it’s diagnosis and treatment. There is always an on-going debate regarding the origin of UA. Immunohistochemical studies help us to know the nature of the lesion and also to differentiate the same from other cysts of odontogenic origin. Hence, it is essential that studies should be conducted on a large scale in order to know the origin and nature of the lesion.


White SC, Pharoah MJ. Oral radiology: Principles and interpretation, 5th edition, Missouri, Mosby, 2004, p384-409,410-57.
White SC, Pharoah MJ. Oral radiology: Principles and interpretation, 5th edition, Missouri, Mosby, 2004, p410-57.
Langlais RP, Langland OE, Nortjé CJ. Multilocular radiolucencies, chapter !3, Diagnostic Imaging of jaws. Williams and Wilkins, 1995,p327-84.
Shaffer WG, Hine MK, Levy BM. A text book of Oral Pathology; 4th edition, W.B. Saunders company, Philadelphia, 1993, p258-317.
Rajendran R, Sivapathasundharam B. Shafer’s textbook of Oral Pathology, 5th edition, Elsevier, New Delhi, 2006, p381-91.
Krammer IRH, Pindborg JJ, Shear M. WHO international Histological Classification of Tumors. Histological typing of Odontogenic Tumors, 2nd Edition Berlin-Heidelberg-New York: Springer Verlag: 1992 p11-4.
Peter A Reichart, Hans P Philipsen. Odontogenic tumors and allied lesions by editorial and consensus conference held in Lyon, France (WHO,IARD) in july 2003 in conjunction with prepartion of new WHO Blue Book vol Pathology and genetics of tumors of head and neck, Quintessence publishing co ltd, United Kingdom, 2004, p21-23
Robinson L, Martinez MG. Unicystic ameloblastoma. A prognostically distinct entity. Cancer 1977;40:2278-85.
Peter A Reichart, Hans P Philipsen. Odontogenic tumors and allied lesions by editorial and consensus conference held in Lyon, France (WHO,IARD) in july 2003 in conjunction with prepartion of new WHO Blue Book vol Pathology and genetics of tumors of head and neck, Quintessence publishing co ltd, United Kingdom, 2004, p77-86.
Gardner DG. Plexiform unicystic ameloblastoma- a diagnostic problem in dentigerous cysts. Cancer 1981;47:1358-1363.
Li T-J, Wu Y-T, Yu S-F, Yu G-Y. Unicystic ameloblastoma- a clinicopathological study of 33 chinese patients. Am J Surg Pathol 2000;24:1385-92.
Eversole LR, Leider AS, Strub D. Radiographic characteristics of cytogenic ameloblastoma. Oral Surg Oral med Oral Pathol 1984;57:572-77.
Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oncol 1995;31B:86-99.
Ackerman GL, Altini M, Shear M. The Unicystic ameloblastoma- clinicopathologic study of 57 cases. J Oral Pathol 1988;17:541-46.
Philipsen HP, Reichart PA. Unicystic ameloblastoma- a review of 193 cases from literature. Oral Oncol 1998;34:317-25.
Neville BW, Damm DD, Allen CM, Bouqout JE. Odontogenic cysts and tumors, chapter 15, in Oral and maxillofacial pathology 2nd edition, W.B. Saunders company, 2002, p589-642.
Leider AS, Eversole LR, Barkin ME. Cystic ameloblastoma. Oral Surg Oral med Oral Pathol 1985;60:624-630.
Li TJ, Browne RM, Matthews JB. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology 1995;26:219-28.
Li TJ, Browne RM, Matthews JB. Epithelial cell proliferation in odntogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS) associated lesions. J Oral Pathol Med 1995;24:221-26
Saku T, Shibata Y, Koyama Z, Cheng J, Okabe H, Yeh Y. Lectin histochemistry of cystic jaw lesions: an aid for differential diagnosis between cystic ameloblastoma and odontogenic cysts. J Oral Pathol Med 1991; 20:108-13.
Gardner DG. Some current concepts on pathology of ameloblastomas. Oral Surg Oral med Oral Pathol Oral Radiol Endod 1996;82:660-69.
Gardner DG, Corio RL. Plexiform unicystic ameloblastoma with a low-recurrence rate after enucleation. Cancer 1984;53:1730-35

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)